98%
921
2 minutes
20
Brain function is shaped by the coordinated activity of billions of neurons. The neurotransmitters and neuromodulators released from these neurons work together to modulate circuit function and, ultimately, behavior. Electroanalytical technologies are particularly valuable for simultaneous detection of multiple biomolecular targets in a single assay. However, to date, most studies that have investigated rapid neurochemical dynamics have targeted a single analyte at a time─usually dopamine. Information on how chemical signals fluctuate relative to one another is largely limited to assays that use electrode arrays (with one target per recording site), while multianalyte detection at single electrodes remains relatively under-developed. This review provides a comprehensive discussion of the strengths and weaknesses associated with classic approaches to molecular monitoring in the brain─microdialysis sampling, electroanalytical techniques, and photometric approaches─and key advances toward multianalyte sensing at single recording sites. The codetection of multiple analytes at the same space and time promises to provide an entirely new perspective on brain function (and dysfunction) that can be exploited to inform on the development of improved therapeutic strategies to treat neurological disorders, broadly speaking.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acschemneuro.5c00286 | DOI Listing |
J Neural Transm (Vienna)
September 2025
Sárospatak College, Sztárai Institute, University of Tokaj, Eötvöst str. 7, Sárospatak, 3944, Hungary.
Generalized Anxiety Disorder (GAD) is characterized by excessive worry and physical symptoms of prolonged anxiety. Patients with subclinical GAD-states (sub-GAD) do not fulfill the diagnostic criteria of GAD, but they often show a disease burden similar to GAD, and the subclinical state may turn into a full syndrome. Neuroinflammation may contribute to changes in brain structures in sub-GAD, but direct evidence remains lacking.
View Article and Find Full Text PDFJ Neurooncol
September 2025
Institute of Medical Biostatistics, Epidemiology, and Informatics (IMBEI), University Medical Center Mainz, Mainz, Germany.
Purpose: Patients diagnosed with high-grade gliomas (HGG) often experience substantial psychosocial dis-tress. However, due to neurological and neurocognitive deficits its assessment remains challenging, and needs remain unmet. We compared a novel face-to-face assessment during doctor-patient conversations with questionnaire-based screening.
View Article and Find Full Text PDFBiochem Genet
September 2025
Department of Medical Biology, Cerrahpasa Faculty of Medicine, Istanbul University Cerrahpasa, Kocamustafapasa, 34098, Istanbul, Turkey.
Glioblastoma is the most aggressive and malignant tumor of the central nervous system. Current treatment options, including surgical excision, radiotherapy, and chemotherapy, have Limited efficacy, with a median survival rate of approximately 15 months. To develop novel therapeutics, it is crucial to understand the underlying molecular mechanisms driving glioblastoma.
View Article and Find Full Text PDFMol Psychiatry
September 2025
Nencki Institute of Experimental Biology of Polish Academy of Sciences, 3 Pasteur St., Warsaw, 02-093, Poland.
Alcohol use disorder (AUD) is characterized by pathological motivation to consume alcohol and cognitive inflexibility, leading to excessive alcohol seeking and use. In this study, we investigated the molecular correlates of impaired extinction of alcohol seeking during forced abstinence using a mouse model of AUD in the automated IntelliCage social system. This model distinguished AUD-prone and AUD-resistant animals based on the presence of ≥2 or <2 criteria of AUD, respectively.
View Article and Find Full Text PDFNat Aging
September 2025
Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, Atlanta, GA, USA.
Clinical Alzheimer's disease is currently characterized by cerebral β-amyloidosis associated with cognitive impairment. However, most cases of Alzheimer's disease are associated with multiple neuropathologies at autopsy. The peripheral protein changes associated with these disease endophenotypes are poorly understood.
View Article and Find Full Text PDF